List view / Grid view

David Matthews

 

article

Antibodies In-Depth Focus 2017

Lone Friis and David Matthews discuss developability assessment of therapeutic…

15 March 2017 | By

Lone Friis and David Matthews discuss developability assessment of therapeutic antibodies, and Negin Mokhtari and colleagues explain nanoparticle-mediated enzyme delivery for application in cancer therapy...

article

Developing antibody therapeutics

Monoclonal antibodies have come of age as therapeutics; there are…

10 June 2015 | By

Monoclonal antibodies have come of age as therapeutics; there are now more than 30 antibodies on the market and over 200 in clinical trials. The attractions of therapeutic antibodies lie not only in their potential to make potent drugs but also their relative low risk in comparison to small molecule…